Literature DB >> 24256245

Emerging insights into the mechanistic link between α-synuclein and glucocerebrosidase in Parkinson's disease.

Ryan P McGlinchey1, Jennifer C Lee.   

Abstract

Mutations in the GBA1 gene, encoding the enzyme glucocerebrosidase, cause the lysosomal storage disorder GD (Gaucher's disease), and are associated with the development of PD (Parkinson's disease) and other Lewy body disorders. Interestingly, GBA1 variants are the most common genetic risk factor associated with PD. Although clinical studies argue a strong case towards a link between GBA1 mutations and the development of PD, mechanistic insights have been lacking. In the present article, we review recent findings that have provided some biochemical evidence to bridge this relationship, focusing on the molecular link between two proteins, α-synuclein and glucocerebrosidase, involved in PD and GD respectively.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24256245      PMCID: PMC4164968          DOI: 10.1042/BST20130158

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  41 in total

1.  Increased incidence of Parkinson disease among relatives of patients with Gaucher disease.

Authors:  Assaf Halperin; Deborah Elstein; Ari Zimran
Journal:  Blood Cells Mol Dis       Date:  2006-05-02       Impact factor: 3.039

Review 2.  Gaucher disease.

Authors:  Terry D Butters
Journal:  Curr Opin Chem Biol       Date:  2007-07-23       Impact factor: 8.822

3.  A feedforward loop links Gaucher and Parkinson's diseases?

Authors:  Mark R Cookson
Journal:  Cell       Date:  2011-07-08       Impact factor: 41.582

4.  CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy.

Authors:  S Pablo Sardi; Jennifer Clarke; Cathrine Kinnecom; Thomas J Tamsett; Lingyun Li; Lisa M Stanek; Marco A Passini; Gregory A Grabowski; Michael G Schlossmacher; Richard L Sidman; Seng H Cheng; Lamya S Shihabuddin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

Review 5.  Glucocerebrosidase, a new player changing the old rules in Lewy body diseases.

Authors:  Na-Young Yang; Yu-Na Lee; He-Jin Lee; Yoon Suk Kim; Seung-Jae Lee
Journal:  Biol Chem       Date:  2013-07       Impact factor: 3.915

6.  Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones.

Authors:  Chunzhang Yang; Shervin Rahimpour; Jie Lu; Karel Pacak; Barbara Ikejiri; Roscoe O Brady; Zhengping Zhuang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-31       Impact factor: 11.205

7.  Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.

Authors:  Valerie Cullen; S Pablo Sardi; Juliana Ng; You-Hai Xu; Ying Sun; Julianna J Tomlinson; Piotr Kolodziej; Ilana Kahn; Paul Saftig; John Woulfe; Jean-Christophe Rochet; Marcie A Glicksman; Seng H Cheng; Gregory A Grabowski; Lamya S Shihabuddin; Michael G Schlossmacher
Journal:  Ann Neurol       Date:  2011-04-06       Impact factor: 10.422

Review 8.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

9.  A novel α-synuclein missense mutation in Parkinson disease.

Authors:  Christos Proukakis; Christopher G Dudzik; Timothy Brier; Donna S MacKay; J Mark Cooper; Glenn L Millhauser; Henry Houlden; Anthony H Schapira
Journal:  Neurology       Date:  2013-02-20       Impact factor: 9.910

10.  Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells.

Authors:  Georgia Dermentzaki; Evangelia Dimitriou; Maria Xilouri; Helen Michelakakis; Leonidas Stefanis
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more
  8 in total

1.  A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues.

Authors:  Gina M Moriarty; Michael P Olson; Tamr B Atieh; Maria K Janowska; Sagar D Khare; Jean Baum
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

Review 2.  Iron and Neurodegeneration: Is Ferritinophagy the Link?

Authors:  Giorgio Biasiotto; Diego Di Lorenzo; Silvana Archetti; Isabella Zanella
Journal:  Mol Neurobiol       Date:  2015-10-14       Impact factor: 5.590

3.  Structural features of membrane-bound glucocerebrosidase and α-synuclein probed by neutron reflectometry and fluorescence spectroscopy.

Authors:  Thai Leong Yap; Zhiping Jiang; Frank Heinrich; James M Gruschus; Candace M Pfefferkorn; Marilia Barros; Joseph E Curtis; Ellen Sidransky; Jennifer C Lee
Journal:  J Biol Chem       Date:  2014-11-26       Impact factor: 5.157

4.  Dissociation of glucocerebrosidase dimer in solution by its co-factor, saposin C.

Authors:  James M Gruschus; Zhiping Jiang; Thai Leong Yap; Stephanie A Hill; Alexander Grishaev; Grzegorz Piszczek; Ellen Sidransky; Jennifer C Lee
Journal:  Biochem Biophys Res Commun       Date:  2015-01-17       Impact factor: 3.575

5.  Membrane Interactions of α-Synuclein Probed by Neutrons and Photons.

Authors:  Upneet Kaur; Jennifer C Lee
Journal:  Acc Chem Res       Date:  2021-01-08       Impact factor: 22.384

6.  C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.

Authors:  Ryan P McGlinchey; Shannon M Lacy; Katherine E Huffer; Nahid Tayebi; Ellen Sidransky; Jennifer C Lee
Journal:  J Biol Chem       Date:  2019-05-15       Impact factor: 5.157

Review 7.  Bypassing the blood-brian barrier using established skull base reconstruction techniques.

Authors:  Marcel M Miyake; Benjamin S Bleier
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2015-10-23

8.  Gait asymmetry in glucocerebrosidase mutation carriers with Parkinson's disease.

Authors:  Anjali Gera; Joan A O'Keefe; Bichun Ouyang; Yuanqing Liu; Samantha Ruehl; Mark Buder; Jessica Joyce; Nicolette Purcell; Gian Pal
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.